Volume 10, Number 11, November 2004

Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira,* Christopher P. Neukermans,† and Gillian D. Sanders†‡
*Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; and ‡Duke University, Durham, North Carolina, USA

Appendix Figure 1. Prevalence of HPV-16 and HPV-18. A) HPV-16 prevalence in women. B) HPV-16 prevalence in men. C) HPV-18 prevalence in women. D) HPV-18 prevalence in men.

EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z

This page last reviewed October 6, 2004

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention